Efficacy and Safety of Ixekizumab for the Treatment of Plaque Psoriasis: Results through 108 Weeks Randomised, Phase III Clinical Trial (UNCOVER-3)

Author(s):  
Martin Dossenbach (non author presenter)
2017 ◽  
Vol 4 (4) ◽  
pp. 359
Author(s):  
Bhavesh Lakdawala ◽  
Mahemubin S. Lahori ◽  
Ganpat K. Vankar ◽  
Akshay Chandurkar ◽  
Suyog V. Jaiswal ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document